AI assistant
STAAR SURGICAL CO — Director's Dealing 2021
Mar 3, 2021
31996_dirs_2021-03-03_853d04bb-aa0c-4b97-b773-0d14d0546839.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-03-01
Reporting Person: Holliday Keith (Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-01 | Common Stock | S | 5208 | $103.85 | Disposed | 29124 | Direct |
| 2021-03-01 | Common Stock | M | 1206 | $9.30 | Acquired | 30330 | Direct |
| 2021-03-01 | Common Stock | M | 7094 | $16.15 | Acquired | 37424 | Direct |
| 2021-03-01 | Common Stock | M | 1873 | $29.80 | Acquired | 39297 | Direct |
| 2021-03-01 | Common Stock | M | 3610 | $35.98 | Acquired | 42907 | Direct |
| 2021-03-01 | Common Stock | S | 13783 | $104.82 | Disposed | 29124 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-01 | Common Stock Options | $9.30 | M | 1206 | Disposed | 2027-03-20 | Common Stock (1206) | Direct |
| 2021-03-01 | Common Stock Options | $16.15 | M | 7094 | Disposed | 2028-03-14 | Common Stock (7094) | Direct |
| 2021-03-01 | Common Stock Options | $29.80 | M | 1873 | Disposed | 2028-06-13 | Common Stock (1873) | Direct |
| 2021-03-01 | Common Stock Options | $35.98 | M | 3610 | Disposed | 2029-03-13 | Common Stock (3610) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.55 to $106.64, inclusive.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.14 to $106.56, inclusive.
F3: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/13/2021.
F4: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.